INTRODUCTION: b-Thalassemia major (TM) and thalassemia intermedia (TI) are forms of inherited hemoglobinopathies. Our aim was to evaluate a population of asymptomatic TM and TI patients using cardiovascular magnetic resonance (CMR). We hypothesized that the TI group could be differentiated from the TM group based on T2*. We also hypothesized that the TI group would demonstrate significantly higher cardiac output compared to the TM group. PATIENTS AND METHODS: Twenty-one consecutive TI patients aged 23(19-25) years, 21 TM patients and 21 age and sex matched controls were studied. Evaluation of heart, liver T2* relaxation time and right and left ventricular parameters was performed using a 1.5 T system. RESULTS: Myocardial and liver T2* values were significantly higher in TI patients compared to TM (34.35 +/- 2.36 vs 15.77 +/- 3.53 m, P < 0.001 and 5.12 +/- 6.52 vs 1.36 +/- 0.53 ms, P < 0.001, respectively). Controls had myocardial T2* 35.07 +/- 4.52 ms (similar to TI patients, but significantly increased compared to TM patients, P < 0.001) and liver T2* 26.28 +/- 2.37 ms (significantly increased compared to both TI and TM patients, P < 0.001). Left ventricular end-diastolic (LVEDV), end-systolic (LVESV) volumes and left ventricular ejection fraction (LVEF) were higher in TI patients compared to TM (P < 0.001). Stroke volume (LVSV), cardiac output (LVCO) and cardiac index (LVCI) were similarly increased in TI patients compared to TM (P < 0.001). Right ventricular end-diastolic volume (RVEDV), right ventricular end-systolic volume (RVESV) and right ventricular ejection fraction (RVEF) were higher in TI patients compared to TM (P < 0.001). CONCLUSIONS: Although in TM iron plays a crucial role in the evolution of the disease, in TI the high output cardiac state seems to be the most prominent finding.
INTRODUCTION: b-Thalassemia major (TM) and thalassemia intermedia (TI) are forms of inherited hemoglobinopathies. Our aim was to evaluate a population of asymptomatic TM and TI patients using cardiovascular magnetic resonance (CMR). We hypothesized that the TI group could be differentiated from the TM group based on T2*. We also hypothesized that the TI group would demonstrate significantly higher cardiac output compared to the TM group. PATIENTS AND METHODS: Twenty-one consecutive TI patients aged 23(19-25) years, 21 TM patients and 21 age and sex matched controls were studied. Evaluation of heart, liver T2* relaxation time and right and left ventricular parameters was performed using a 1.5 T system. RESULTS: Myocardial and liver T2* values were significantly higher in TI patients compared to TM (34.35 +/- 2.36 vs 15.77 +/- 3.53 m, P < 0.001 and 5.12 +/- 6.52 vs 1.36 +/- 0.53 ms, P < 0.001, respectively). Controls had myocardial T2* 35.07 +/- 4.52 ms (similar to TI patients, but significantly increased compared to TM patients, P < 0.001) and liver T2* 26.28 +/- 2.37 ms (significantly increased compared to both TI and TM patients, P < 0.001). Left ventricular end-diastolic (LVEDV), end-systolic (LVESV) volumes and left ventricular ejection fraction (LVEF) were higher in TI patients compared to TM (P < 0.001). Stroke volume (LVSV), cardiac output (LVCO) and cardiac index (LVCI) were similarly increased in TI patients compared to TM (P < 0.001). Right ventricular end-diastolic volume (RVEDV), right ventricular end-systolic volume (RVESV) and right ventricular ejection fraction (RVEF) were higher in TI patients compared to TM (P < 0.001). CONCLUSIONS: Although in TM iron plays a crucial role in the evolution of the disease, in TI the high output cardiac state seems to be the most prominent finding.
Authors: John C Wood; Cathleen Enriquez; Nilesh Ghugre; J Michael Tyzka; Susan Carson; Marvin D Nelson; Thomas D Coates Journal: Blood Date: 2005-04-28 Impact factor: 22.113
Authors: A Aessopos; D Farmakis; M Karagiorga; E Voskaridou; A Loutradi; A Hatziliami; J Joussef; J Rombos; D Loukopoulos Journal: Blood Date: 2001-06-01 Impact factor: 22.113
Authors: M G Zurlo; P De Stefano; C Borgna-Pignatti; A Di Palma; A Piga; C Melevendi; F Di Gregorio; M G Burattini; S Terzoli Journal: Lancet Date: 1989-07-01 Impact factor: 79.321
Authors: N F Olivieri; D G Nathan; J H MacMillan; A S Wayne; P P Liu; A McGee; M Martin; G Koren; A R Cohen Journal: N Engl J Med Date: 1994-09-01 Impact factor: 91.245
Authors: P Liu; M Henkelman; J Joshi; P Hardy; J Butany; M Iwanochko; M Clauberg; M Dhar; D Mai; S Waien; N Olivieri Journal: Can J Cardiol Date: 1996-02 Impact factor: 5.223
Authors: M Beth McCarville; Claudia M Hillenbrand; Ralf B Loeffler; Matthew P Smeltzer; Ruitan Song; Chin-Shang Li; Jane S Hankins Journal: Pediatr Radiol Date: 2010-03-24
Authors: Sophie Mavrogeni; Konstantinos Bratis; Kees van Wijk; Louisa Kyrou; Antonios Kattamis; Johan H C Reiber Journal: Int J Cardiovasc Imaging Date: 2013-08-20 Impact factor: 2.357